Want to join the conversation?
$MDT announced findings from two clinical studies, the first validating the clinical utility of its Integrated Pulmonary Index in the post anesthesia care unit to identify respiratory adverse events, and the second, a study on the cost-effectiveness of capnography in gastrointestinal sedation.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.